Sevelamer Hydrochloride in Peritoneal Dialysis Patients
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
To test the hypothesis that second-line fixed low-dose sevelamer hydrochloride therapy is as
effective as first-line high-dose sevelamer hydrochloride therapy in limiting the progression
of cardiovascular calcification.